bar_chartArbutus Biopharma Corporation
ABUS | Healthcare | Biotechnology
bar_chartPerformance
bar_chartPerformance(Quarter)
bar_chartCash Flow
bar_chartCash Flow(Quarter)
bar_chartInstitutional Holders
Holder |
% Out |
Shares |
RTW Investments LP |
7.04% |
5,978,355 |
Foresite Capital Management IV, LLC |
3.92% |
3,332,616 |
Morgan Stanley |
3.43% |
2,909,716 |
Vanguard Group, Inc. (The) |
2.64% |
2,240,898 |
Think Investments LP |
2.36% |
2,000,000 |
Advisor Group, Inc. |
1.6% |
1,360,289 |
Blackrock Inc. |
1.23% |
1,045,394 |
Hudson Bay Capital Management LP |
0.84% |
710,000 |
Ameriprise Financial, Inc. |
0.77% |
655,499 |
Primecap Management Company |
0.59% |
500,000 |
bar_chartMutual Fund Holders
Holder |
% Out |
Shares |
Vanguard Total Stock Market Index Fund |
1.21% |
1,031,555 |
Vanguard Extended Market Index Fund |
0.84% |
717,469 |
Primecap Odyssey Aggressive Growth Fund |
0.59% |
500,000 |
Fidelity Extended Market Index Fund |
0.22% |
183,569 |
AMG Managers Cadence Emerging Companies Fd |
0.17% |
140,368 |
iShares Micro Cap ETF |
0.15% |
130,732 |
Fidelity NASDAQ Composite Index Tracking Stock |
0.08% |
66,847 |
Vanguard Institutional Index-Inst Total Stock Market Ind |
0.07% |
60,124 |
Fidelity Total Market Index Fund |
0.05% |
46,367 |
ETF Managers Tr-ETFMG Treatments, Testing and Advancements ETF |
0.05% |
45,373 |